Table 6.
Outcomes for patients with pterygium and facial filler injections.
| Total HBO2a treatments | Pretreatment EQ-5D VASb | Posttreatment EQ-5D VAS | Pretreatment EQ-5D score | Posttreatment EQ-5D score | Reason for missing EQ-5D | Notes on outcome | |
| Pterygium surgery | |||||||
|
|
5 | 85 | 75 | 1 | 0.83 | —c | Uneventful |
|
|
5 | 90 | 90 | 0.88 | 1 | — | No postoperative problems |
|
|
5 | 90 | 100 | 0.86 | 1 | — | No postoperative problems |
|
|
5 | 80 | 100 | 0.83 | 1 | — | — |
|
|
5 | 70 | 100 | 0.88 | 1 | — | — |
|
|
5 | 70 | 95 | 0.82 | 1 | — | — |
|
|
5 | — | — | — | — | Not done | — |
| Facial filler injection | |||||||
|
|
6 | — | — | — | — | Unable | Improved |
|
|
1 | 95 | — | 0.81 | — | Postictal state | Had seizure |
|
|
5 | 75 | 85 | 0.82 | 1 | — | Improvement in bruising or ischemia |
|
|
5 | 95 | — | — | — | Not done | Necrosis improved with HBO2 therapy |
aHBO2: hyperbaric oxygen.
bVAS: visual analog scale.
cNot available.